CD274 and cancer: Taken together, these data demonstrate selective IP-10 induction from antigen positive cancer cell lines using targeted IFN fusions, and MC38 cancer cells treated with anti-PD-L1-mIFN-α induced better migration of activated T cells compared with the control IFN fusion or antibody alone.